McConnell E E, Wilson R E, Moore J A, Haseman J K
Cancer Lett. 1980 Jan;8(3):271-8. doi: 10.1016/0304-3835(80)90013-0.
Weanling male and female F 344 rats were given various doses of 1,2-dimethylhydrazine (DMH) or methylazoxymethyl acetate (MAMAc), and were then held for 46-64 weeks in an effort to determine a dose response and establish a dose level which would produce a low level of intestinal neoplasia with a minimal number of tumors in other organs. DMH proved superior to MAM in this respect, although liver lesions were still observed with both compounds at the lowest carcinogenic intestinal dose.